Thomas A Zelniker Selected Research

Thomas A Zelniker Research Topics

Disease

15	Myocardial Infarction 03/2022 - 10/2018
15	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2019
14	Heart Failure 01/2022 - 12/2017
8	Stroke (Strokes) 03/2022 - 10/2018
8	Atrial Fibrillation 01/2022 - 03/2019
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2019
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 03/2019
5	Hemorrhage 12/2021 - 03/2019
3	Out-of-Hospital Cardiac Arrest 12/2021 - 11/2020
3	Ischemic Stroke 01/2020 - 01/2019
3	Kidney Diseases (Kidney Disease) 01/2020 - 01/2019
2	Hypertension (High Blood Pressure) 01/2022 - 01/2021
2	Diabetes Mellitus 11/2021 - 01/2021
2	Acute Coronary Syndrome 01/2021 - 01/2019
2	Albuminuria 01/2021 - 01/2021
2	Chronic Renal Insufficiency 01/2021 - 01/2020
2	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2021 - 01/2019
1	Unstable Angina 03/2022
1	Inflammation (Inflammations) 11/2021
1	Hemorrhagic Stroke 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Coronary Disease (Coronary Heart Disease) 01/2021
1	Ischemia 01/2021
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2021
1	Ventricular Tachycardia 01/2021
1	Ventricular Remodeling 01/2020
1	Peripheral Arterial Disease 01/2020
1	Chest Pain (Chest Pains) 01/2020
1	Thrombosis (Thrombus) 09/2019
1	Renal Insufficiency (Renal Failure) 02/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2019
1	Infections 01/2019
1	Pulmonary Arterial Hypertension 06/2018
1	Pulmonary Hypertension 06/2018
1	Myocardial Ischemia (Ischemic Heart Diseases) 12/2017

Drug/Important Bio-Agent (IBA)

11	dapagliflozinIBA 11/2021 - 01/2019
9	Sodium-Glucose Transport ProteinsIBA 01/2021 - 01/2019
7	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 10/2018
6	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2019
5	omega-Chloroacetophenone (Mace)IBA 03/2022 - 01/2019
4	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 03/2019
4	SodiumIBA 01/2021 - 10/2018
4	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2020 - 01/2019
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 01/2019
3	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 01/2021
3	CreatinineIBA 01/2021 - 01/2019
2	C-Reactive ProteinIBA 01/2022 - 01/2019
2	Troponin T (Troponin T1)IBA 11/2021 - 01/2019
2	AnticoagulantsIBA 01/2021 - 09/2019
2	edoxabanIBA 01/2021 - 03/2019
2	SymportersIBA 01/2021 - 10/2018
2	Vitamin K FDA Link 01/2021 - 09/2019
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2019
1	LDL CholesterolIBA 01/2022
1	TroponinIBA 12/2021
1	saxagliptin FDA Link 11/2021
1	Proprotein Convertase 9IBA 01/2021
1	evolocumabIBA 01/2021
1	Ranolazine FDA Link 01/2021
1	docosapentaenoic acidIBA 01/2021
1	AlbuminsIBA 01/2021
1	Docosahexaenoic AcidsIBA 01/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021
1	LipidsIBA 01/2021
1	SmokeIBA 01/2021
1	Eicosapentaenoic AcidIBA 01/2021
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2021
1	Factor Xa (Coagulation Factor Xa)IBA 01/2021
1	alpha-Linolenic Acid (Linolenic Acid)IBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Neurofibromin 2 (Merlin)IBA 01/2021
1	Neprilysin (Neutral Endopeptidase)IBA 11/2020
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2020
1	N(4)-oleylcytosine arabinosideIBA 09/2019
1	Factor Xa InhibitorsIBA 03/2019
1	Glucagon-Like Peptide ReceptorsIBA 01/2019
1	CollagenIBA 01/2019
1	Growth Differentiation Factor 15IBA 01/2019
1	empagliflozinIBA 10/2018
1	CanagliflozinIBA 10/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2017

Therapy/Procedure

6	Therapeutics 01/2021 - 12/2017
1	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2021
1	Critical Care (Surgical Intensive Care) 12/2021
1	Surgical Amputation (Amputations) 01/2021
1	Electrodes (Electrode) 01/2020
1	Secondary Prevention 01/2019
1	Kidney Transplantation 01/2019